U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Name Type Language
BROLUCIZUMAB-DBLL
FDA  
Preferred Name English
BEOVU
Brand Name English
Brolucizumab dbll [WHO-DD]
Common Name English
Code System Code Type Description
BIOLOGIC SUBSTANCE CLASSIFICATION CODE
XSZ53G39H5-DBLL-01
Created by admin on Sat Dec 16 15:04:20 GMT 2023 , Edited by admin on Sat Dec 16 15:04:20 GMT 2023
PRIMARY